Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment

Neuroscience Letters

Volumn 550, Issue , 2013, Pages 60-63

  Huang, Li ^a   Jia, Jianping ^a   Liu, Ruiqin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amnestic mild cognitive impairment; Angiogenesis; CDR; TGF 1; VEGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALZHEIMER'S DISEASE; AMNESTIC MILD COGNITIVE IMPAIRMENT; ANGIOGENESIS; CDR; TGF-Β1; VEGF;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMNESIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84881372319     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.031     Document Type: Article

References (24)

1. Bailey T.L., Rivara C.B., Rocher A.B., Hof P.R. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol. Res. 2004, 26:573-578.
2. Caraci F., Battaglia G., Bruno V., Bosco P., Carbonaro V., Giuffrida M.L., Drago F., Sortino M.A., Nicoletti F., Copani A. TGF-beta1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci. Ther. 2011, 17:237-249.
3. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
4. Chiappelli M., Borroni B., Archetti S., Calabrese E., Corsi M.M., Franceschi M., Padovani A., Licastro F. VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Res. 2006, 9:485-493.
5. De Servi B., La Porta C.A., Bontempelli M., Comolli R. Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease. Exp. Gerontol. 2002, 37:813-821.
6. Del Bo R., Ghezzi S., Scarpini E., Bresolin N., Comi G.P. VEGF genetic variability is associated with increased risk of developing Alzheimer's disease. J. Neurol. Sci. 2009, 283:66-68.
7. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 2001, 64:575-611.
8. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003, 9:669-676.
9. Gerwins P., Skoldenberg E., Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit. Rev. Oncol. Hematol. 2000, 34:185-194.
10. Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science 2006, 314:777-781.
11. Greenberg D.A., Jin K. VEGF and ALS: the luckiest growth factor?. Trends Mol. Med. 2004, 10:1-3.
12. Kataru R.P., Jung K., Jang C., Yang H., Schwendener R.A., Baik J.E., Han S.H., Alitalo K., Koh G.Y. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009, 113:5650-5659.
13. Luck T., Luppa M., Briel S., Riedel-Heller S.G. Incidence of mild cognitive impairment: a systematic review. Dement. Geriatr. Cogn. Disord. 2010, 29:164-175.
14. Matsuo R., Ago T., Kamouchi M., Kuroda J., Kuwashiro T., Hata J., Sugimori H., Fukuda K., Gotoh S., Makihara N., Fukuhara M., Awano H., Isomura T., Suzuki K., Yasaka M., Okada Y., Kiyohara Y., Kitazono T. Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study. BMC Neurol. 2013, 13:32.
15. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
16. Nowacka M.M., Obuchowicz E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 2012, 46:1-10.
17. Pradeep C.R., Sunila E.S., Kuttan G. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr. Cancer Ther. 2005, 4:315-321.
18. Spuch C., Antequera D., Portero A., Orive G., Hernandez R.M., Molina J.A., Bermejo-Pareja F., Pedraz J.L., Carro E. The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials 2010, 31:5608-5618.
19. Teraoka H., Sawada T., Nishihara T., Yashiro M., Ohira M., Ishikawa T., Nishino H., Hirakawa K. Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer. Br. J. Cancer 2001, 85:612-617.
20. Wang P., Xie Z.H., Guo Y.J., Zhao C.P., Jiang H., Song Y., Zhu Z.Y., Lai C., Xu S.L., Bi J.Z. VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease. Biochem. Biophys. Res. Commun. 2011, 411:620-626.
21. Weiss R., Lifshitz V., Frenkel D. TGF-beta1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis. Brain Behav. Immun. 2011, 25:1017-1024.
22. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., Mucke L. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 2001, 7:612-618.
23. Yang S.P., Bae D.G., Kang H.J., Gwag B.J., Gho Y.S., Chae C.B. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiol. Aging 2004, 25:283-290.
24. Yang S.P., Kwon B.O., Gho Y.S., Chae C.B. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity. J. Neurochem. 2005, 93:118-127.